APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alimta

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Alimta Market Analysis and Forecast 2026-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchAlimta Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Alimta Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Alimta Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alimta Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Alimta Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Alimta market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Alimta is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Alimta is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Alimta is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Alimta is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Alimta include Eagle Pharmaceuticals, Eli Lilly, Cadila Healthcare and Abbott Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Alimta, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Alimta, also provides the sales of main regions and countries. Of the upcoming market potential for Alimta, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alimta sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Alimta market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Alimta sales, projected growth trends, production technology, application and end-user industry.

Alimta Segment by Company

Eagle Pharmaceuticals

Eli Lilly

Cadila Healthcare

Abbott Healthcare

Alimta Segment by Type

100mg

500mg

Alimta Segment by Application

Pleural Mesothelioma

Non-small Cell Lung Cancer

Alimta Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alimta market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alimta and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alimta.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Alimta in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Alimta manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alimta sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Alimta Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100mg Major Manufacturers Table 3. 500mg Major Manufacturers Table 4. Global Alimta Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pleural Mesothelioma Major Manufacturers Table 6. Non-small Cell Lung Cancer Major Manufacturers Table 7. Alimta Industry Trends Table 8. Alimta Industry Drivers Table 9. Alimta Industry Opportunities and Challenges Table 10. Alimta Industry Restraints Table 11. Global Alimta Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Alimta Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Alimta Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Alimta Revenue Market Share by Region (2021-2026) Table 15. Global Alimta Revenue Market Share by Region (2027-2032) Table 16. Global Alimta Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 17. Global Alimta Sales by Region (2021-2026) & (kg) Table 18. Global Alimta Sales by Region (2027-2032) & (kg) Table 19. Global Alimta Sales Market Share by Region (2021-2026) Table 20. Global Alimta Sales Market Share by Region (2027-2032) Table 21. Global Alimta Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Alimta Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Alimta Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Alimta Sales Market Share by Manufacturers (2021-2026) Table 25. Global Alimta Sales Price (US$/g) of Manufacturers (2021-2026) Table 26. Global Alimta Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Alimta Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Alimta Manufacturers, Product Type & Application Table 29. Global Alimta Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Alimta by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Alimta Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Alimta Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Alimta Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Alimta Revenue Market Share by Type (2021-2026) Table 36. Global Alimta Revenue Market Share by Type (2027-2032) Table 37. Global Alimta Sales by Type 2021 VS 2025 VS 2032 (kg) Table 38. Global Alimta Sales by Type (2021-2026) & (kg) Table 39. Global Alimta Sales by Type (2027-2032) & (kg) Table 40. Global Alimta Sales Market Share by Type (2021-2026) Table 41. Global Alimta Sales Market Share by Type (2027-2032) Table 42. Global Alimta Price by Type (2021-2026) & (US$/g) Table 43. Global Alimta Price by Type (2027-2032) & (US$/g) Table 44. Global Alimta Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Alimta Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Alimta Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Alimta Revenue Market Share by Application (2021-2026) Table 48. Global Alimta Revenue Market Share by Application (2027-2032) Table 49. Global Alimta Sales by Application 2021 VS 2025 VS 2032 (kg) Table 50. Global Alimta Sales by Application (2021-2026) & (kg) Table 51. Global Alimta Sales by Application (2027-2032) & (kg) Table 52. Global Alimta Sales Market Share by Application (2021-2026) Table 53. Global Alimta Sales Market Share by Application (2027-2032) Table 54. Global Alimta Price by Application (2021-2026) & (US$/g) Table 55. Global Alimta Price by Application (2027-2032) & (US$/g) Table 56. Eagle Pharmaceuticals Company Information Table 57. Eagle Pharmaceuticals Business Overview Table 58. Eagle Pharmaceuticals Alimta Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 59. Eagle Pharmaceuticals Alimta Product Portfolio Table 60. Eagle Pharmaceuticals Recent Development Table 61. Eli Lilly Company Information Table 62. Eli Lilly Business Overview Table 63. Eli Lilly Alimta Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 64. Eli Lilly Alimta Product Portfolio Table 65. Eli Lilly Recent Development Table 66. Cadila Healthcare Company Information Table 67. Cadila Healthcare Business Overview Table 68. Cadila Healthcare Alimta Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 69. Cadila Healthcare Alimta Product Portfolio Table 70. Cadila Healthcare Recent Development Table 71. Abbott Healthcare Company Information Table 72. Abbott Healthcare Business Overview Table 73. Abbott Healthcare Alimta Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 74. Abbott Healthcare Alimta Product Portfolio Table 75. Abbott Healthcare Recent Development Table 76. North America Alimta Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Alimta Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Alimta Sales by Type (2021-2026) & (kg) Table 79. North America Alimta Sales by Type (2027-2032) & (kg) Table 80. North America Alimta Sales Price by Type (2021-2026) & (US$/g) Table 81. North America Alimta Sales Price by Type (2027-2032) & (US$/g) Table 82. North America Alimta Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Alimta Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Alimta Sales by Application (2021-2026) & (kg) Table 85. North America Alimta Sales by Application (2027-2032) & (kg) Table 86. North America Alimta Sales Price by Application (2021-2026) & (US$/g) Table 87. North America Alimta Sales Price by Application (2027-2032) & (US$/g) Table 88. North America Alimta Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Alimta Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 90. North America Alimta Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 91. North America Alimta Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 92. North America Alimta Sales by Country (2021-2026) & (kg) Table 93. North America Alimta Sales by Country (2027-2032) & (kg) Table 94. North America Alimta Sales Price by Country (2021-2026) & (US$/g) Table 95. North America Alimta Sales Price by Country (2027-2032) & (US$/g) Table 96. United States Alimta Revenue (2021-2032) & (US$ Million) Table 97. Canada Alimta Revenue (2021-2032) & (US$ Million) Table 98. Mexico Alimta Revenue (2021-2032) & (US$ Million) Table 99. Europe Alimta Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Alimta Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Alimta Sales by Type (2021-2026) & (kg) Table 102. Europe Alimta Sales by Type (2027-2032) & (kg) Table 103. Europe Alimta Sales Price by Type (2021-2026) & (US$/g) Table 104. Europe Alimta Sales Price by Type (2027-2032) & (US$/g) Table 105. Europe Alimta Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Alimta Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Alimta Sales by Application (2021-2026) & (kg) Table 108. Europe Alimta Sales by Application (2027-2032) & (kg) Table 109. Europe Alimta Sales Price by Application (2021-2026) & (US$/g) Table 110. Europe Alimta Sales Price by Application (2027-2032) & (US$/g) Table 111. Europe Alimta Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Alimta Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. Europe Alimta Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. Europe Alimta Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 115. Europe Alimta Sales by Country (2021-2026) & (kg) Table 116. Europe Alimta Sales by Country (2027-2032) & (kg) Table 117. Europe Alimta Sales Price by Country (2021-2026) & (US$/g) Table 118. Europe Alimta Sales Price by Country (2027-2032) & (US$/g) Table 119. Germany Alimta Revenue (2021-2032) & (US$ Million) Table 120. France Alimta Revenue (2021-2032) & (US$ Million) Table 121. U.K. Alimta Revenue (2021-2032) & (US$ Million) Table 122. Italy Alimta Revenue (2021-2032) & (US$ Million) Table 123. Russia Alimta Revenue (2021-2032) & (US$ Million) Table 124. Spain Alimta Revenue (2021-2032) & (US$ Million) Table 125. Netherlands Alimta Revenue (2021-2032) & (US$ Million) Table 126. Switzerland Alimta Revenue (2021-2032) & (US$ Million) Table 127. Sweden Alimta Revenue (2021-2032) & (US$ Million) Table 128. Poland Alimta Revenue (2021-2032) & (US$ Million) Table 129. China Alimta Revenue by Type (2021-2026) & (US$ Million) Table 130. China Alimta Revenue by Type (2027-2032) & (US$ Million) Table 131. China Alimta Sales by Type (2021-2026) & (kg) Table 132. China Alimta Sales by Type (2027-2032) & (kg) Table 133. China Alimta Sales Price by Type (2021-2026) & (US$/g) Table 134. China Alimta Sales Price by Type (2027-2032) & (US$/g) Table 135. China Alimta Revenue by Application (2021-2026) & (US$ Million) Table 136. China Alimta Revenue by Application (2027-2032) & (US$ Million) Table 137. China Alimta Sales by Application (2021-2026) & (kg) Table 138. China Alimta Sales by Application (2027-2032) & (kg) Table 139. China Alimta Sales Price by Application (2021-2026) & (US$/g) Table 140. China Alimta Sales Price by Application (2027-2032) & (US$/g) Table 141. Asia Alimta Revenue by Type (2021-2026) & (US$ Million) Table 142. Asia Alimta Revenue by Type (2027-2032) & (US$ Million) Table 143. Asia Alimta Sales by Type (2021-2026) & (kg) Table 144. Asia Alimta Sales by Type (2027-2032) & (kg) Table 145. Asia Alimta Sales Price by Type (2021-2026) & (US$/g) Table 146. Asia Alimta Sales Price by Type (2027-2032) & (US$/g) Table 147. Asia Alimta Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Alimta Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Alimta Sales by Application (2021-2026) & (kg) Table 150. Asia Alimta Sales by Application (2027-2032) & (kg) Table 151. Asia Alimta Sales Price by Application (2021-2026) & (US$/g) Table 152. Asia Alimta Sales Price by Application (2027-2032) & (US$/g) Table 153. Asia Alimta Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia Alimta Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Asia Alimta Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Asia Alimta Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 157. Asia Alimta Sales by Country (2021-2026) & (kg) Table 158. Asia Alimta Sales by Country (2027-2032) & (kg) Table 159. Asia Alimta Sales Price by Country (2021-2026) & (US$/g) Table 160. Asia Alimta Sales Price by Country (2027-2032) & (US$/g) Table 161. Japan Alimta Revenue (2021-2032) & (US$ Million) Table 162. South Korea Alimta Revenue (2021-2032) & (US$ Million) Table 163. India Alimta Revenue (2021-2032) & (US$ Million) Table 164. Australia Alimta Revenue (2021-2032) & (US$ Million) Table 165. Taiwan Alimta Revenue (2021-2032) & (US$ Million) Table 166. Southeast Asia Alimta Revenue (2021-2032) & (US$ Million) Table 167. SAMEA Alimta Revenue by Type (2021-2026) & (US$ Million) Table 168. SAMEA Alimta Revenue by Type (2027-2032) & (US$ Million) Table 169. SAMEA Alimta Sales by Type (2021-2026) & (kg) Table 170. SAMEA Alimta Sales by Type (2027-2032) & (kg) Table 171. SAMEA Alimta Sales Price by Type (2021-2026) & (US$/g) Table 172. SAMEA Alimta Sales Price by Type (2027-2032) & (US$/g) Table 173. SAMEA Alimta Revenue by Application (2021-2026) & (US$ Million) Table 174. SAMEA Alimta Revenue by Application (2027-2032) & (US$ Million) Table 175. SAMEA Alimta Sales by Application (2021-2026) & (kg) Table 176. SAMEA Alimta Sales by Application (2027-2032) & (kg) Table 177. SAMEA Alimta Sales Price by Application (2021-2026) & (US$/g) Table 178. SAMEA Alimta Sales Price by Application (2027-2032) & (US$/g) Table 179. SAMEA Alimta Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. SAMEA Alimta Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. SAMEA Alimta Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. SAMEA Alimta Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 183. SAMEA Alimta Sales by Country (2021-2026) & (kg) Table 184. SAMEA Alimta Sales by Country (2027-2032) & (kg) Table 185. SAMEA Alimta Sales Price by Country (2021-2026) & (US$/g) Table 186. SAMEA Alimta Sales Price by Country (2027-2032) & (US$/g) Table 187. Brazil Alimta Revenue (2021-2032) & (US$ Million) Table 188. Argentina Alimta Revenue (2021-2032) & (US$ Million) Table 189. Chile Alimta Revenue (2021-2032) & (US$ Million) Table 190. Colombia Alimta Revenue (2021-2032) & (US$ Million) Table 191. Peru Alimta Revenue (2021-2032) & (US$ Million) Table 192. Saudi Arabia Alimta Revenue (2021-2032) & (US$ Million) Table 193. Israel Alimta Revenue (2021-2032) & (US$ Million) Table 194. UAE Alimta Revenue (2021-2032) & (US$ Million) Table 195. Turkey Alimta Revenue (2021-2032) & (US$ Million) Table 196. Iran Alimta Revenue (2021-2032) & (US$ Million) Table 197. Egypt Alimta Revenue (2021-2032) & (US$ Million) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Alimta Distributors List Table 201. Alimta Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Alimta Image Figure 2. Global Alimta Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alimta Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100mg Image Figure 5. 500mg Image Figure 6. Global Alimta Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Alimta Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pleural Mesothelioma Image Figure 9. Non-small Cell Lung Cancer Image Figure 10. Global Alimta Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Alimta Revenue (2021-2032) & (US$ Million) Figure 12. Global Alimta Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Alimta Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Alimta Revenue Market Share by Region (2021-2032) Figure 15. Global Alimta Sales (2021-2032) & (kg) Figure 16. Global Alimta Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 17. Global Alimta Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Alimta Sales YoY (2021-2032) & (kg) Figure 19. Europe Alimta Sales YoY (2021-2032) & (kg) Figure 20. China Alimta Sales YoY (2021-2032) & (kg) Figure 21. Asia (Excluding China) Alimta Sales YoY (2021-2032) & (kg) Figure 22. South America, Middle East and Africa Alimta Sales YoY (2021-2032) & (kg) Figure 23. Global Alimta Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Alimta Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Alimta Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Alimta Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Alimta Revenue Market Share by Type (2021-2032) Figure 29. Global Alimta Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 30. Global Alimta Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Alimta Sales Market Share by Type (2021-2032) Figure 32. Global Alimta Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Alimta Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Alimta Revenue Market Share by Application (2021-2032) Figure 35. Global Alimta Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 36. Global Alimta Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Alimta Sales Market Share by Application (2021-2032) Figure 38. North America Alimta Revenue Share by Type (2021-2032) Figure 39. North America Alimta Sales Share by Type (2021-2032) Figure 40. North America Alimta Revenue Share by Application (2021-2032) Figure 41. North America Alimta Sales Share by Application (2021-2032) Figure 42. North America Alimta Revenue Share by Country (2021-2032) Figure 43. North America Alimta Sales Share by Country (2021-2032) Figure 44. Europe Alimta Revenue Share by Type (2021-2032) Figure 45. Europe Alimta Sales Share by Type (2021-2032) Figure 46. Europe Alimta Revenue Share by Application (2021-2032) Figure 47. Europe Alimta Sales Share by Application (2021-2032) Figure 48. Europe Alimta Revenue Share by Country (2021-2032) Figure 49. Europe Alimta Sales Share by Country (2021-2032) Figure 50. China Alimta Revenue Share by Type (2021-2032) Figure 51. China Alimta Sales Share by Type (2021-2032) Figure 52. China Alimta Revenue Share by Application (2021-2032) Figure 53. China Alimta Sales Share by Application (2021-2032) Figure 54. Asia Alimta Revenue Share by Type (2021-2032) Figure 55. Asia Alimta Sales Share by Type (2021-2032) Figure 56. Asia Alimta Revenue Share by Application (2021-2032) Figure 57. Asia Alimta Sales Share by Application (2021-2032) Figure 58. Asia Alimta Revenue Share by Country (2021-2032) Figure 59. Asia Alimta Sales Share by Country (2021-2032) Figure 60. SAMEA Alimta Revenue Share by Type (2021-2032) Figure 61. SAMEA Alimta Sales Share by Type (2021-2032) Figure 62. SAMEA Alimta Revenue Share by Application (2021-2032) Figure 63. SAMEA Alimta Sales Share by Application (2021-2032) Figure 64. SAMEA Alimta Revenue Share by Country (2021-2032) Figure 65. SAMEA Alimta Sales Share by Country (2021-2032) Figure 66. Alimta Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Alimta Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 500mg
Applications
  • Pleural Mesothelioma
  • Non-small Cell Lung Cancer
Companies covered
  • Eagle Pharmaceuticals
  • Eli Lilly
  • Cadila Healthcare
  • Abbott Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Alimta Market by Type
  3. 1.2.1 Global Alimta Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100mg
  5. 1.2.3 500mg
  6. 1.3 Alimta Market by Application
  7. 1.3.1 Global Alimta Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pleural Mesothelioma
  9. 1.3.3 Non-small Cell Lung Cancer
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Alimta Market Dynamics
  1. 2.1 Alimta Industry Trends
  2. 2.2 Alimta Industry Drivers
  3. 2.3 Alimta Industry Opportunities and Challenges
  4. 2.4 Alimta Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Alimta Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Alimta Revenue by Region
  3. 3.2.1 Global Alimta Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Alimta Revenue by Region (2021-2026)
  5. 3.2.3 Global Alimta Revenue by Region (2027-2032)
  6. 3.2.4 Global Alimta Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Alimta Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Alimta Sales by Region
  9. 3.4.1 Global Alimta Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Alimta Sales by Region (2021-2026)
  11. 3.4.3 Global Alimta Sales by Region (2027-2032)
  12. 3.4.4 Global Alimta Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Alimta Revenue by Manufacturers
  2. 4.1.1 Global Alimta Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Alimta Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Alimta Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Alimta Sales by Manufacturers
  6. 4.2.1 Global Alimta Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Alimta Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Alimta Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Alimta Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Alimta Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Alimta Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Alimta Manufacturers, Product Type & Application
  13. 4.7 Global Alimta Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Alimta Market CR5 and HHI
  16. 4.8.2 2025 Alimta Tier 1, Tier 2, and Tier 3
5 Alimta Market by Type
  1. 5.1 Global Alimta Revenue by Type
  2. 5.1.1 Global Alimta Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Alimta Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Alimta Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Alimta Sales by Type
  6. 5.2.1 Global Alimta Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alimta Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global Alimta Sales Market Share by Type (2021-2032)
  9. 5.3 Global Alimta Price by Type
6 Alimta Market by Application
  1. 6.1 Global Alimta Revenue by Application
  2. 6.1.1 Global Alimta Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Alimta Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Alimta Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Alimta Sales by Application
  6. 6.2.1 Global Alimta Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Alimta Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global Alimta Sales Market Share by Application (2021-2032)
  9. 6.3 Global Alimta Price by Application
7 Company Profiles
  1. 7.1 Eagle Pharmaceuticals
  2. 7.1.1 Eagle Pharmaceuticals Company Information
  3. 7.1.2 Eagle Pharmaceuticals Business Overview
  4. 7.1.3 Eagle Pharmaceuticals Alimta Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Eagle Pharmaceuticals Alimta Product Portfolio
  6. 7.1.5 Eagle Pharmaceuticals Recent Developments
  7. 7.2 Eli Lilly
  8. 7.2.1 Eli Lilly Company Information
  9. 7.2.2 Eli Lilly Business Overview
  10. 7.2.3 Eli Lilly Alimta Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly Alimta Product Portfolio
  12. 7.2.5 Eli Lilly Recent Developments
  13. 7.3 Cadila Healthcare
  14. 7.3.1 Cadila Healthcare Company Information
  15. 7.3.2 Cadila Healthcare Business Overview
  16. 7.3.3 Cadila Healthcare Alimta Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Cadila Healthcare Alimta Product Portfolio
  18. 7.3.5 Cadila Healthcare Recent Developments
  19. 7.4 Abbott Healthcare
  20. 7.4.1 Abbott Healthcare Company Information
  21. 7.4.2 Abbott Healthcare Business Overview
  22. 7.4.3 Abbott Healthcare Alimta Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Abbott Healthcare Alimta Product Portfolio
  24. 7.4.5 Abbott Healthcare Recent Developments
8 North America
  1. 8.1 North America Alimta Market Size by Type
  2. 8.1.1 North America Alimta Revenue by Type (2021-2032)
  3. 8.1.2 North America Alimta Sales by Type (2021-2032)
  4. 8.1.3 North America Alimta Price by Type (2021-2032)
  5. 8.2 North America Alimta Market Size by Application
  6. 8.2.1 North America Alimta Revenue by Application (2021-2032)
  7. 8.2.2 North America Alimta Sales by Application (2021-2032)
  8. 8.2.3 North America Alimta Price by Application (2021-2032)
  9. 8.3 North America Alimta Market Size by Country
  10. 8.3.1 North America Alimta Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Alimta Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Alimta Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Alimta Market Size by Type
  2. 9.1.1 Europe Alimta Revenue by Type (2021-2032)
  3. 9.1.2 Europe Alimta Sales by Type (2021-2032)
  4. 9.1.3 Europe Alimta Price by Type (2021-2032)
  5. 9.2 Europe Alimta Market Size by Application
  6. 9.2.1 Europe Alimta Revenue by Application (2021-2032)
  7. 9.2.2 Europe Alimta Sales by Application (2021-2032)
  8. 9.2.3 Europe Alimta Price by Application (2021-2032)
  9. 9.3 Europe Alimta Market Size by Country
  10. 9.3.1 Europe Alimta Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Alimta Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Alimta Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Alimta Market Size by Type
  2. 10.1.1 China Alimta Revenue by Type (2021-2032)
  3. 10.1.2 China Alimta Sales by Type (2021-2032)
  4. 10.1.3 China Alimta Price by Type (2021-2032)
  5. 10.2 China Alimta Market Size by Application
  6. 10.2.1 China Alimta Revenue by Application (2021-2032)
  7. 10.2.2 China Alimta Sales by Application (2021-2032)
  8. 10.2.3 China Alimta Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Alimta Market Size by Type
  2. 11.1.1 Asia Alimta Revenue by Type (2021-2032)
  3. 11.1.2 Asia Alimta Sales by Type (2021-2032)
  4. 11.1.3 Asia Alimta Price by Type (2021-2032)
  5. 11.2 Asia Alimta Market Size by Application
  6. 11.2.1 Asia Alimta Revenue by Application (2021-2032)
  7. 11.2.2 Asia Alimta Sales by Application (2021-2032)
  8. 11.2.3 Asia Alimta Price by Application (2021-2032)
  9. 11.3 Asia Alimta Market Size by Country
  10. 11.3.1 Asia Alimta Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Alimta Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Alimta Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Alimta Market Size by Type
  2. 12.1.1 SAMEA Alimta Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Alimta Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Alimta Price by Type (2021-2032)
  5. 12.2 SAMEA Alimta Market Size by Application
  6. 12.2.1 SAMEA Alimta Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Alimta Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Alimta Price by Application (2021-2032)
  9. 12.3 SAMEA Alimta Market Size by Country
  10. 12.3.1 SAMEA Alimta Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Alimta Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Alimta Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Alimta Value Chain Analysis
  2. 13.1.1 Alimta Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Alimta Production Mode & Process
  6. 13.2 Alimta Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Alimta Distributors
  9. 13.2.3 Alimta Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst